- Home
- EDUC vs ICU Comparison
EDUC vs ICU Comparison
Compare EDUC & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDUC
- ICU
- Stock Information
- Founded
- EDUC 1965
- ICU 2018
- Country
- EDUC United States
- ICU United States
- Employees
- EDUC N/A
- ICU N/A
- Industry
- EDUC Consumer Specialties
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- EDUC Consumer Discretionary
- ICU Health Care
- Exchange
- EDUC Nasdaq
- ICU Nasdaq
- Market Cap
- EDUC 11.4M
- ICU 9.5M
- IPO Year
- EDUC N/A
- ICU N/A
- Fundamental
- Price
- EDUC $1.30
- ICU $0.66
- Analyst Decision
- EDUC
- ICU
- Analyst Count
- EDUC 0
- ICU 0
- Target Price
- EDUC N/A
- ICU N/A
- AVG Volume (30 Days)
- EDUC 8.5K
- ICU 5.7M
- Earning Date
- EDUC 07-07-2025
- ICU 08-12-2025
- Dividend Yield
- EDUC N/A
- ICU N/A
- EPS Growth
- EDUC N/A
- ICU N/A
- EPS
- EDUC N/A
- ICU N/A
- Revenue
- EDUC $31,304,000.00
- ICU $428,000.00
- Revenue This Year
- EDUC N/A
- ICU $754.07
- Revenue Next Year
- EDUC N/A
- ICU $100.09
- P/E Ratio
- EDUC N/A
- ICU N/A
- Revenue Growth
- EDUC N/A
- ICU N/A
- 52 Week Low
- EDUC $0.92
- ICU $0.31
- 52 Week High
- EDUC $2.49
- ICU $9.09
- Technical
- Relative Strength Index (RSI)
- EDUC 45.48
- ICU 45.72
- Support Level
- EDUC $1.30
- ICU $0.53
- Resistance Level
- EDUC $1.40
- ICU $0.94
- Average True Range (ATR)
- EDUC 0.05
- ICU 0.10
- MACD
- EDUC 0.00
- ICU 0.01
- Stochastic Oscillator
- EDUC 28.64
- ICU 30.91
About EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.